Addition of Certain Entities to the Entity List, Revision of Entries on the Entity List and Removal of Certain Entities From the Entity List, 46103-46104 [C2-2018-18766]
Download as PDF
Federal Register / Vol. 83, No. 177 / Wednesday, September 12, 2018 / Rules and Regulations
These amended special conditions
will provide head injury criteria, neck
injury criteria, spine injury criteria, and
body-to-wall contact criteria. They
contain the additional safety standards
that the Administrator considers
necessary to establish a level of safety
equivalent to that established by the
existing airworthiness standards.
Applicability
As discussed above, these special
conditions are applicable to the Boeing
Model 777 series airplane. Should
Boeing apply at a later date for a change
to the type certificate to include another
model incorporating the same novel or
unusual design feature, these special
conditions would apply to that model as
well.
Conclusion
This action affects only certain novel
or unusual design features on one model
series of airplanes. It is not a rule of
general applicability.
List of Subjects in 14 CFR Part 25
Aircraft, Aviation safety, Reporting
and recordkeeping requirements.
Authority Citation
The authority citation for these
special conditions is as follows:
Authority: 49 U.S.C. 106(f), 106(g), 40113,
44701, 44702, 44704.
The Special Conditions
Accordingly, pursuant to the
authority delegated to me by the
Administrator, the following special
conditions are issued as part of the type
certification basis for the Boeing Model
777 series airplanes.
Side-Facing Seats Special Conditions
In addition to the requirements of
§ 25.562:
1. Head Injury Criteria (HIC)
Compliance with § 25.562(c)(5) is
required, except that, if the ATD has no
apparent contact with the seat/structure
but has contact with an airbag, a HIC
unlimited score in excess of 1,000 is
acceptable, provided the HIC15 score for
that contact (calculated in accordance
with 49 CFR 571.208) is less than 700.
daltland on DSKBBV9HB2PROD with RULES
2. Body-to-Wall/Furnishing Contact
If a seat is installed aft of structure
(e.g., interior wall or furnishings) that
does not provide a homogenous contact
surface for the expected range of
occupants and yaw angles, then
additional analysis and tests may be
required to demonstrate that the injury
VerDate Sep<11>2014
16:01 Sep 11, 2018
Jkt 244001
criteria are met for the area which an
occupant could contact. For example,
different yaw angles could result in
different airbag device performance,
then additional analysis or separate tests
may be necessary to evaluate
performance.
6. Femur Criteria
3. Neck Injury Criteria
The seating system must protect the
occupant from experiencing serious
neck injury. The assessment of neck
injury must be conducted with the
airbag device activated, unless there is
a reason to also consider that the neckinjury potential would be higher for
impacts below the airbag-device
deployment threshold.
a. The Nij, calculated in accordance
with 49 CFR 571.208, must be below
1.0, where Nij = Fz/Fzc + My/Myc, and Nij
critical values are:
7. ATD and Test Conditions
i. Fzc = 1,530 lbs for tension
ii. Fzc = 1,385 lbs for compression
iii. Myc = 229 lb-ft in flexion
iv. Myc = 100 lb-ft in extension
b. In addition, peak upper-neck Fz
must be below 937 lbs. in tension and
899 lbs. in compression.
c. Rotation of the head about its
vertical axis, relative to the torso is
limited to 105 degrees in either
direction from forward-facing.
d. The neck must not impact any
surface that would produce
concentrated loading on the neck.
4. Spine and Torso Injury Criteria:
a. The lumbar spine tension (Fz)
cannot exceed 1,200 lbs.
b. Significant concentrated loading on
the occupant’s spine, in the area
between the pelvis and shoulders
during impact, including rebound, is
not acceptable. During this type of
contact, the interval for any rearward (X
direction) acceleration exceeding 20 g
must be less than 3 milliseconds as
measured by the thoracic
instrumentation specified in 49 CFR
part 572, subpart E, filtered in
accordance with SAE recommended
practice J211/1, ‘‘Instrumentation for
Impact Test–Part 1—Electronic
Instrumentation.’’
c. The occupant must not interact
with the armrest or other seat
components in any manner significantly
different than would be expected for a
forward-facing seat installation.
5. Pelvis Criteria
Any part of the load-bearing portion
of the bottom of the ATD pelvis must
not translate beyond the edges of the
seat bottom seat-cushion supporting
structure.
PO 00000
Frm 00035
Fmt 4700
Sfmt 4700
46103
Axial rotation of the upper leg (about
the z-axis of the femur per SAE
Recommended Practice J211/1) must be
limited to 35 degrees from the nominal
seated position. Evaluation during
rebound does not need to be considered.
Longitudinal tests conducted to
measure the injury criteria above must
be performed with the FAA Hybrid III
ATD, as described in SAE 1999–01–
1609, ‘‘A Lumbar Spine Modification to
the Hybrid III ATD for Aircraft Seat
Tests.’’ The tests must be conducted
with an undeformed floor, at the mostcritical yaw cases for injury, and with
all lateral structural supports (e.g.,
armrests or walls) installed.
Issued in Des Moines, Washington, on
September 5, 2018.
Victor Wicklund,
Manager, Transport Standards Branch, Policy
and Innovation Division, Aircraft
Certification Service.
[FR Doc. 2018–19752 Filed 9–11–18; 8:45 am]
BILLING CODE 4910–13–P
DEPARTMENT OF COMMERCE
Bureau of Industry and Security
15 CFR Part 744
[Docket No. 180718671–8671–01]
RIN 0694–AH57
Addition of Certain Entities to the
Entity List, Revision of Entries on the
Entity List and Removal of Certain
Entities From the Entity List
Correction
In rule document 2018–18766
beginning on page 44821 in the issue of
Tuesday, September 4, 2018, make the
following correction:
1. On page 44824, in the third
column, amendatory instruction number
2e is corrected to read as follows:
‘‘2. * * *
e. Under Russia,
i. By removing the entity ‘‘Joint Stock
Company Mikron’’;
ii. By adding in alphabetical order
two entities ‘‘Joint Stock Company (JSC)
NIIME’’ and ‘‘PJSC Mikron’’;
2. On page 44825, in the table, under
the country heading for Hong Kong, the
Joinus Freight Systems entry should
read as follows:
*
*
*
*
*
E:\FR\FM\12SER1.SGM
12SER1
46104
Federal Register / Vol. 83, No. 177 / Wednesday, September 12, 2018 / Rules and Regulations
Joinus Freight Systems (H.K.) Limited, a.k.a., the
following two aliases:
–JFS Global Logistics; and.
–Joinus Freight Systems Global Logistics Limited.
Unit 07–07, 25F, Tower B, Regent Centre, 63 Wo
Yi Hop Road, Kwai Chung, N.T. Hong Kong and
Units 801–803 and 805, Park Sun Building, No.
97–107 Wo Yi Hop Road, Kwai Chung, Hong
Kong.
*
*
*
*
*
*
*
*
Proezd
12/1,
*
For all items subject to the EAR.
(See § 744.11 of the EAR).
Presumption of
denial.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Effective September 12, 2018,
FDA withdraws amendatory instruction
13 on page 56144 of the final rule
published at 80 FR 55908 at 56144 on
September 17, 2015. Submit either
electronic or written comments by
October 12, 2018.
Food and Drug Administration
ADDRESSES:
DATES:
[FR Doc. C2–2018–18766 Filed 9–11–18; 8:45 am]
BILLING CODE 1301–00–D
21 CFR Part 110
[Docket No. FDA–2011–N–0920]
Current Good Manufacturing Practice,
Hazard Analysis, and Risk-Based
Preventive Controls for Human Food
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Final rule; partial withdrawal.
The Food and Drug
Administration (FDA, the Agency, or
we) is removing instruction 13 from the
Current Good Manufacturing Practice,
Hazard Analysis, and Risk-Based
Preventive Controls for Human Food
(Preventive Controls for Human Food)
regulation. Instruction 13 directs the
Federal Register to remove and reserve
as of September 17, 2018, the Current
Good Manufacturing Practice in
Manufacturing, Packing, or Holding
Human Food (Human Food CGMP)
regulation. Removal of instruction 13 is
necessary because the compliance dates
for certain facilities subject to the
modernized current good manufacturing
practice requirements in the Preventive
Controls for Human Food regulation
have been extended. Retaining the
Human Food CGMP regulation will
maintain the status quo while these
facilities prepare for compliance with
the new CGMP requirements and will
avoid an unintended gap in public
health protection.
SUMMARY:
daltland on DSKBBV9HB2PROD with RULES
Presumption of
denial.
VerDate Sep<11>2014
17:36 Sep 11, 2018
81 FR 14958, 3/21/16. 83 FR [Insert
FR Page Number] 9/4/2018.
3. On page 44826, in the table, under
the country heading for Russia, the PJSC
Mikron entry should read as follows:
*
*
*
*
*
PJSC Mikron, 1st Zapadniy
Zelenograd, Russia, 124460.
*
For all items subject to the EAR.
(See § 744.11 of the EAR).
Jkt 244001
You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before October 12,
2018. The https://www.regulations.gov
electronic filing system will accept
comments until midnight Eastern Time
at the end of October 12, 2018.
Comments received by mail/hand
delivery/courier (for written/paper
submissions) will be considered timely
if they are postmarked or the delivery
service acceptance receipt is on or
before that date.
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
PO 00000
Frm 00036
Fmt 4700
Sfmt 4700
81 FR 61601, 9/7/16. 83 FR [Insert
FR Page Number] 9/4/2018.
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2011–N–0920 for ‘‘Current Good
Manufacturing Practice, Hazard
Analysis, and Risk-Based Preventive
Controls for Human Food.’’ Received
comments, those filed in a timely
manner (see ADDRESSES), will be placed
in the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
E:\FR\FM\12SER1.SGM
12SER1
Agencies
[Federal Register Volume 83, Number 177 (Wednesday, September 12, 2018)]
[Rules and Regulations]
[Pages 46103-46104]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: C2-2018-18766]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Bureau of Industry and Security
15 CFR Part 744
[Docket No. 180718671-8671-01]
RIN 0694-AH57
Addition of Certain Entities to the Entity List, Revision of
Entries on the Entity List and Removal of Certain Entities From the
Entity List
Correction
In rule document 2018-18766 beginning on page 44821 in the issue of
Tuesday, September 4, 2018, make the following correction:
1. On page 44824, in the third column, amendatory instruction
number 2e is corrected to read as follows:
``2. * * *
e. Under Russia,
i. By removing the entity ``Joint Stock Company Mikron'';
ii. By adding in alphabetical order two entities ``Joint Stock
Company (JSC) NIIME'' and ``PJSC Mikron'';
2. On page 44825, in the table, under the country heading for Hong
Kong, the Joinus Freight Systems entry should read as follows:
* * * * *
[[Page 46104]]
----------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------
Joinus Freight Systems (H.K.) For all items subject Presumption of denial.. 81 FR 14958, 3/21/16.
Limited, a.k.a., the following two to the EAR. (See Sec. 83 FR [Insert FR Page
aliases: 744.11 of the EAR). Number] 9/4/2018.
-JFS Global Logistics; and.......
-Joinus Freight Systems Global
Logistics Limited.
Unit 07-07, 25F, Tower B, Regent
Centre, 63 Wo Yi Hop Road, Kwai
Chung, N.T. Hong Kong and Units 801-
803 and 805, Park Sun Building, No.
97-107 Wo Yi Hop Road, Kwai Chung,
Hong Kong.
----------------------------------------------------------------------------------------------------------------
* * * * *
3. On page 44826, in the table, under the country heading for
Russia, the PJSC Mikron entry should read as follows:
* * * * *
----------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------
PJSC Mikron, 1st Zapadniy Proezd 12/ For all items subject Presumption of denial.. 81 FR 61601, 9/7/16. 83
1, Zelenograd, Russia, 124460. to the EAR. (See Sec. FR [Insert FR Page
744.11 of the EAR). Number] 9/4/2018.
----------------------------------------------------------------------------------------------------------------
* * * * *
[FR Doc. C2-2018-18766 Filed 9-11-18; 8:45 am]
BILLING CODE 1301-00-D